-+ 0.00%
-+ 0.00%
-+ 0.00%

Akari Therapeutics Awards Interim CFO Kameel Farag 2,873 Restricted Stock Units

PUBT·11/19/2026 22:27:03
Akari Therapeutics Awards Interim CFO Kameel Farag 2,873 Restricted Stock Units
  • Akari Therapeutics interim CFO Kameel D. Farag received 2,873 American Depositary Shares representing Ordinary Shares on November 17, 2026.
  • His direct holdings totaled 26,182 American Depositary Shares following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akari Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-053314), on November 19, 2026, and is solely responsible for the information contained therein.